Laryngorhinootologie 2024; 103(S 02): S231-S232
DOI: 10.1055/s-0044-1784759
Abstracts │ DGHNOKHC
Experimental Oncology

Tissue-resident memory CD8 T cells as a prognostic marker in sinonasal Squamous Cell Carcinoma

Patricia Mack
1   Universitätsklinikum Würzburg, Klinik und Poliklinik für Hals-, Nasen-, Ohrenkrankheiten, plastische und ästhetische Operationen, Würzburg
,
Manuel Stöth
1   Universitätsklinikum Würzburg, Klinik und Poliklinik für Hals-, Nasen-, Ohrenkrankheiten, plastische und ästhetische Operationen, Würzburg
,
Joshua Mannal
1   Universitätsklinikum Würzburg, Klinik und Poliklinik für Hals-, Nasen-, Ohrenkrankheiten, plastische und ästhetische Operationen, Würzburg
,
Till Meyer
1   Universitätsklinikum Würzburg, Klinik und Poliklinik für Hals-, Nasen-, Ohrenkrankheiten, plastische und ästhetische Operationen, Würzburg
,
Pascal Ickrath
1   Universitätsklinikum Würzburg, Klinik und Poliklinik für Hals-, Nasen-, Ohrenkrankheiten, plastische und ästhetische Operationen, Würzburg
,
Stephan Hackenberg
1   Universitätsklinikum Würzburg, Klinik und Poliklinik für Hals-, Nasen-, Ohrenkrankheiten, plastische und ästhetische Operationen, Würzburg
,
Agmal Scherzad
1   Universitätsklinikum Würzburg, Klinik und Poliklinik für Hals-, Nasen-, Ohrenkrankheiten, plastische und ästhetische Operationen, Würzburg
› Institutsangaben
 
 

    Introduction Immune cells of the tumor microenvironment (TME) play a crucial role in tumor biology. Part of this TME are CD103+tissue-resident memory CD8 T cells (Trm). However, the role of Trm in sinonasal squamous cell carcinoma (SNSCC) is unclear. The aim of this work is to characterize Trm in SNSCC and to investigate their impact on disease prognosis.

    Methods Flow cytometry was used to detect and characterize Trm in human SNSCC tissue. Furthermore, CD103+and CD8+cells were quantified in a retrospective cohort of 77 SNSCC patients using immunohistochemistry (IHC). The patients were assigned to groups CD103high and CD103low as well as CD8high and CD8low based on the median of the determined cell count. Survival curves were generated using Kaplan-Meier curves and compared with the log-rank test.

    Results Using flow cytometry CD3+CD8+CD69+CD103+cells were detected in the tumors of SNSCC patients, but not in their blood. With IHC CD103+cells were also detected in all patients. The overall survival in the groups CD8high and CD103high was significantly better than in the groups CD8low and CD103low (p=0,0083; p=0,0437). The disease-free survival was significantly better in CD8high (p=0,0394) than in CD8low patients. For CD103 no differences in terms of disease-free survival were found.

    Discussion Trm could be identified as a component of the TME in SNSCC. In our cohort, the number of CD103+as well as CD8+cells in tumor tissue correlates significantly with the prognosis of the disease.


    #

    Publikationsverlauf

    Artikel online veröffentlicht:
    19. April 2024

    © 2024. Thieme. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany